176 related articles for article (PubMed ID: 32753650)
1. ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.
Qi L; Wang ZY; Shao XR; Li M; Chen SN; Liu XQ; Yan S; Zhang B; Zhang XD; Li X; Zhao W; Pan JA; Zhao B; Zhang XD
Oncogene; 2020 Sep; 39(37):5964-5978. PubMed ID: 32753650
[TBL] [Abstract][Full Text] [Related]
2. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
[TBL] [Abstract][Full Text] [Related]
3. Case report: ISL2 is involved in malignant transformation in a patient with multiple relapsed oligodendroglioma.
Chen SN; Wang Z; Zhou DS; Liu XQ; Mai TY; Dong ZX; Li M; Zhang XD; Qi L
Front Oncol; 2022; 12():969191. PubMed ID: 35965581
[TBL] [Abstract][Full Text] [Related]
4. Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis.
Chen Z; Zhu S; Hong J; Soutto M; Peng D; Belkhiri A; Xu Z; El-Rifai W
Gut; 2016 Jun; 65(6):925-34. PubMed ID: 25779598
[TBL] [Abstract][Full Text] [Related]
5. Lhx3 is required to maintain cancer cell development of high-grade oligodendroglioma.
Liu H; Liu W; Zhu B; Xu Q; Ni X; Yu J
Mol Cell Biochem; 2015 Jan; 399(1-2):1-5. PubMed ID: 25399296
[TBL] [Abstract][Full Text] [Related]
6. Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression.
Le Mercier M; Fortin S; Mathieu V; Roland I; Spiegl-Kreinecker S; Haibe-Kains B; Bontempi G; Decaestecker C; Berger W; Lefranc F; Kiss R
Neoplasia; 2009 May; 11(5):485-96. PubMed ID: 19412433
[TBL] [Abstract][Full Text] [Related]
7. PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction.
Chang HH; Cheng YC; Tsai WC; Chen Y
Cancer Sci; 2020 Nov; 111(11):4142-4153. PubMed ID: 32816328
[TBL] [Abstract][Full Text] [Related]
8. MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma.
Zhu J; Wu Y; Yu Y; Li Y; Shen J; Zhang R
Cell Death Dis; 2022 Aug; 13(8):727. PubMed ID: 35987690
[TBL] [Abstract][Full Text] [Related]
9. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.
Ozturk H; Cingoz H; Tufan T; Yang J; Adair SJ; Tummala KS; Kuscu C; Kinali M; Comertpay G; Nagdas S; Goudreau BJ; Luleyap HU; Bingul Y; Ware TB; Hwang WL; Hsu KL; Kashatus DF; Ting DT; Chandel NS; Bardeesy N; Bauer TW; Adli M
Dev Cell; 2022 Jun; 57(11):1331-1346.e9. PubMed ID: 35508175
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic modulation of gliomagenesis by Pax6 and Olig2 in PDGF-induced oligodendroglioma.
Appolloni I; Calzolari F; Barilari M; Terrile M; Daga A; Malatesta P
Int J Cancer; 2012 Oct; 131(7):E1078-87. PubMed ID: 22514120
[TBL] [Abstract][Full Text] [Related]
11. Analysis of angiogenic markers in oral squamous cell carcinoma-gene and protein expression.
Jung S; Sielker S; Purcz N; Sproll C; Acil Y; Kleinheinz J
Head Face Med; 2015 Jun; 11():19. PubMed ID: 26044849
[TBL] [Abstract][Full Text] [Related]
12. Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells.
Sasagawa T; Jinno-Oue A; Nagamatsu T; Morita K; Tsuruga T; Mori-Uchino M; Fujii T; Shibuya M
BMC Cancer; 2020 Feb; 20(1):112. PubMed ID: 32041578
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/β-catenin and P53 signaling pathways.
Chen HQ; Zhao J; Li Y; Huang YJ; Chen DJ; He LX; Wang LQ; Zheng CF; Wang J; Cao J; Shu WQ; Liu JY; Liu WB
Environ Pollut; 2019 Sep; 252(Pt A):216-226. PubMed ID: 31151060
[TBL] [Abstract][Full Text] [Related]
15. VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer.
Lian L; Li XL; Xu MD; Li XM; Wu MY; Zhang Y; Tao M; Li W; Shen XM; Zhou C; Jiang M
BMC Cancer; 2019 Feb; 19(1):183. PubMed ID: 30819137
[TBL] [Abstract][Full Text] [Related]
16. ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.
Lin CY; Cho CF; Bai ST; Liu JP; Kuo TT; Wang LJ; Lin YS; Lin CC; Lai LC; Lu TP; Hsieh CY; Chu CN; Cheng DC; Sher YP
Sci Rep; 2017 Nov; 7(1):15108. PubMed ID: 29118335
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia.
Jiang Y; Zhou J; Zou D; Hou D; Zhang H; Zhao J; Li L; Hu J; Zhang Y; Jing Z
EBioMedicine; 2019 Oct; 48():36-48. PubMed ID: 31631037
[TBL] [Abstract][Full Text] [Related]
18. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
19. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targetting
Ren L; Wei C; Li K; Lu Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30038058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
